Compare PLETHICO PHARMA with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA PROCTER & GAMBLE HEALTH PLETHICO PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x -1.1 51.5 - View Chart
P/BV x 0.0 4.7 0.4% View Chart
Dividend Yield % 0.0 10.2 -  

Financials

 PLETHICO PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
PROCTER & GAMBLE HEALTH
Dec-18
PLETHICO PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3953,549 11.1%   
Low Rs311,301 2.4%   
Sales per share (Unadj.) Rs604.4511.4 118.2%  
Earnings per share (Unadj.) Rs32.561.3 53.0%  
Cash flow per share (Unadj.) Rs51.374.0 69.3%  
Dividends per share (Unadj.) Rs0440.00 0.0%  
Dividend yield (eoy) %018.1 0.0%  
Book value per share (Unadj.) Rs473.6927.8 51.0%  
Shares outstanding (eoy) m34.0816.60 205.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.44.7 7.4%   
Avg P/E ratio x6.639.6 16.6%  
P/CF ratio (eoy) x4.232.8 12.7%  
Price / Book Value ratio x0.52.6 17.2%  
Dividend payout %0717.9 0.0%   
Avg Mkt Cap Rs m7,26240,257 18.0%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m1,5961,313 121.6%   
Avg. sales/employee Rs ThNM7,486.7-  
Avg. wages/employee Rs ThNM1,157.6-  
Avg. net profit/employee Rs ThNM897.2-  
INCOME DATA
Net Sales Rs m20,5988,490 242.6%  
Other income Rs m386244 158.4%   
Total revenues Rs m20,9848,734 240.3%   
Gross profit Rs m2,8181,482 190.2%  
Depreciation Rs m642211 304.1%   
Interest Rs m1,5930-   
Profit before tax Rs m9691,514 64.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m-138563 -24.6%   
Profit after tax Rs m1,1071,017 108.8%  
Gross profit margin %13.717.5 78.4%  
Effective tax rate %-14.337.1 -38.5%   
Net profit margin %5.412.0 44.8%  
BALANCE SHEET DATA
Current assets Rs m18,87715,343 123.0%   
Current liabilities Rs m11,8961,960 606.9%   
Net working cap to sales %33.9157.6 21.5%  
Current ratio x1.67.8 20.3%  
Inventory Days Days3649 73.7%  
Debtors Days Days19828 695.4%  
Net fixed assets Rs m9,8611,209 815.4%   
Share capital Rs m341166 205.2%   
"Free" reserves Rs m12,33115,235 80.9%   
Net worth Rs m16,13915,401 104.8%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14617,595 188.4%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.5 128.8%   
Return on assets %8.15.8 140.9%  
Return on equity %6.96.6 103.8%  
Return on capital %12.310.3 119.8%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,4021,636 269.0%   
Fx outflow Rs m3,1844,368 72.9%   
Net fx Rs m1,219-2,732 -44.6%   
CASH FLOW
From Operations Rs m2,437-1,304 -186.9%  
From Investments Rs m-6,26512,697 -49.3%  
From Financial Activity Rs m2,490-301 -828.7%  
Net Cashflow Rs m-1,33711,093 -12.1%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 4.3 18.2 23.6%  
FIIs % 5.5 1.0 550.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 29.1 25.8%  
Shareholders   10,665 28,591 37.3%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - VENUS REMEDIES COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS